A systematic review of the side effects of high-intensity focused ultrasound ablation of uterine fibroids
- PMID: 39440094
- PMCID: PMC11492634
- DOI: 10.1080/08998280.2024.2387497
A systematic review of the side effects of high-intensity focused ultrasound ablation of uterine fibroids
Abstract
Background: A new intervention called high-intensity focused ultrasound (HIFU) targets fibroids with high-intensity ultrasound pulses using ultrasound probes. This noninvasive method, which can be carried out with either magnetic resonance imaging or ultrasound guidance, results in immediate coagulated necrosis within a clearly defined area a few millimeters in diameter.
Methods: This systematic review evaluated the safety of HIFU in the treatment of uterine fibroids regardless of site or size. We specifically aimed to determine the incidence of side effects that can occur during and after HIFU. We searched the PubMed, Scopus, ScienceDirect, and Mendeley archive using only the terms HIFU and fibroid. After identifying 1077 studies of different types from 2014 to March 2024, 300 studies were screened and 60 included.
Results: According to Society of Interventional Radiology guidelines, class A adverse events (AEs) showed no significant results, and individuals with these AEs required no treatment and had no long-term consequences. Similarly, there were no class B significant results. However, 3943 of 10,204 patients (38%) complained of lower abdominal pain after the procedure, a class B AE, which resolved by analgesics. Further, 153 of 24,700 patients (0.6%) had skin burns, blisters, or nodules, and these issues resolved with conservative treatment. Additionally, 74 of 23,741 patients (0.3%) had hematuria; 882 of 5970 patients (14.7%) had abnormal vaginal discharge; 414 of 23,449 (1.7%) had vaginal bleeding; and 267 of 7598 (3.5%) had leg paresthesia. Major AEs (class C and D) were almost nonexistent, and the incidence of death in our study was zero.
Conclusion: HIFU ablation of uterine fibroids is generally safe, causing mostly mild side effects and very few severe complications. The relative safety of HIFU compared to other minimally invasive techniques, such as uterine artery embolization, still needs further evaluation.
Keywords: Adverse reaction; HIFU; high-intensity focused ultrasound; uterine fibroids.
Copyright © 2024 Baylor University Medical Center.
Conflict of interest statement
The authors report no funding or conflicts of interest.
Figures
Similar articles
-
Preliminary study on ultrasound-guided high-intensity focused ultrasound ablation for treatment of broad ligament uterine fibroids.Int J Hyperthermia. 2021 Sep;38(2):18-23. doi: 10.1080/02656736.2021.1921287. Int J Hyperthermia. 2021. PMID: 34420440
-
Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.Eur Radiol. 2020 Mar;30(3):1554-1563. doi: 10.1007/s00330-019-06468-2. Epub 2019 Nov 8. Eur Radiol. 2020. PMID: 31705252 Clinical Trial.
-
Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.Ultraschall Med. 2020 Oct;41(5):550-556. doi: 10.1055/a-0891-0729. Epub 2019 Jun 25. Ultraschall Med. 2020. PMID: 31238385 English.
-
Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.Eur J Radiol. 2019 Nov;120:108700. doi: 10.1016/j.ejrad.2019.108700. Epub 2019 Oct 15. Eur J Radiol. 2019. PMID: 31634683
-
Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids - a systematic review and future perspectives.Int J Hyperthermia. 2023;40(1):2174274. doi: 10.1080/02656736.2023.2174274. Int J Hyperthermia. 2023. PMID: 36775655
Cited by
-
Application of high intensity focused ultrasound in the treatment of uterine fibroids in overweight/obese women.BMC Womens Health. 2025 May 22;25(1):243. doi: 10.1186/s12905-025-03797-x. BMC Womens Health. 2025. PMID: 40399833 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources